# Efficacy of Adjuvant Mitotane Treatment (ADIUVO)

> **NCT00777244** · PHASE3 · UNKNOWN · sponsor: **University of Turin, Italy** · enrollment: 200 (estimated)

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

- **DRUG:** MITOTANE

## Key facts

- **NCT ID:** NCT00777244
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777244, "Efficacy of Adjuvant Mitotane Treatment (ADIUVO)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00777244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*